Genetic and molecular basis of cardiac arrhythmias: Impact on clinical management parts I and II

Circulation

Volumn 99, Issue 4, 1999, Pages 518-528

  Priori, Silvia G ^a   Barhanin, Jacques ^a   Hauer, Richard N W ^a   Haverkamp, Wilhelm ^a   Jongsma, Habo J ^a   Kleber, André G ^a   McKenna, William J ^a   Roden, Dan M ^a   Rudy, Yoram ^a   Schwartz, Ketty ^a   Schwartz, Peter J ^a   Towbin, Jeffrey A ^a   Wilde, Arthur M ^a  

^a IRCCS   (Italy)

Author keywords

Arrhythmia; Death; Electrophysiology; Genetics; Molecular biology; Sudden

Indexed keywords

ANTIARRHYTHMIC AGENT;

ARRHYTHMOGENESIS; ARTICLE; GENE LOCUS; GENE MUTATION; GENETIC SCREENING; HEALTH CARE COST; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; MOLECULAR BIOLOGY; MOLECULAR GENETICS; PRIORITY JOURNAL; REIMBURSEMENT;

EID: 0033514256     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.4.518     Document Type: Article

References (94)

1. Schwanz PJ. Idiopathic long QT syndrome: progress and questions. Am Heart J. 1985;109:399-411.
2. Schwartz PJ, Locati EH, Napolitano C, Priori SG. The long QT syndrome. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, Pa: WB Saunders Co; 1995:788-811.
3. Romano C, Gemme G, Pongiglione R. Aritmie cardiache rare dell'età pediatrica. Clin Pediatr. 1963;45:658-683.
4. Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J. 1957;54:59-68.
5. Wang Q, Curran ME, Splawski I. Burn TC, Millholland JM, Van Raay TJ, Shen J, Timothy KW, Vincent GM, de Jager T, Schwartz PJ, Towbin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD, Keating MT. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet. 1996; 12:17-23.
6. Jiang C, Atkinson D, Towbin JA, Splawski I, Lehmann MH, Li H, Timothy K, Taggart RT, Schwartz PJ, Vincent GM, Moss AJ, Keating MT. Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. Nat Genet. 1994;8:141-147.
7. Towbin JA, Li H, Taggart RT, Lehmann MH, Schwartz PJ, Sailer CA, Ayyagari R, Robinson JL, Moss A, Hejtmancik JF. Evidence of genetic heterogeneity in Romano-Ward long QT syndrome: analysis of 23 families. Circulation. 1994;90:2635-2644.
8. Schott JJ, Peltier S, Foley P, Drouin E, Bouhour JB, Donnely P, Vergnaud G, Moisan JP, Le Marée H, Pascal O. Mapping of a new gene for the LQTS syndrome. Am 1 Hum Genet. 1995;57:1114-1122.
9. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, Moss AJ, Towbin JA, Keating MT. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 1995;80:805-811.
10. Benne PB, Yazawa K, Makita N, George AJ. Molecular mechanism for an inherited cardiac arrhythmia. Nature. 1995;376:683-685.
11. Dumaine R, Wang Q, Keating MT, Hartmann HA, Schwanz PJ, Brown AM, Kirsch GE. Multiple mechanisms of Nachannel-linked long-QT syndrome. Circ Res. 1996;78:916-924.
12. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 1995;80:795-803.
13. Sanguinetti MC, Curran ME, Zou A, Shen J, Spector PS, Atkinson DL, Keating MT. Coassembly of KvLQTl and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature. 1996;384:80-83.
14. Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski M, Romey G. K(V)LQT1 and IsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature. 1996;384:78-80.
15. Splawski I, Tristani-Firouzi, M, Lehmannn MH, Sanguinetti MC, Keating MT. Mutations in the hminK gene cause long-QT syndrome and suppress IKs function. Nat Genet. 1997;17:338-340.
16. Schülze-Bahr E, Wang Q, Wedekind H, Haverkamp W, Chen Q, Sun Y. KCNE1 mutations cause Jervell and Lange-Nielsen syndrome. Nat Genet. 1997;17:267-268.
17. De Jager T, Corbett CH, Badenhorst JC, Brink PA, Corfield VA. Evidence of a long QT founder gene with varying phenotypic expression in South African families. J Med Genet. 1996:33:567-573.
18. Napolitano C, Priori SO, Schwanz PJ, Timothy K, Paganini V, Cantù F, Bloise R, De Fusco M, Casari G. Identification of a mutational hot spot in HERG-related long QT-syndrome (LQT2): phenotypic implications. Circulation. 1997;96(suppl I):I-212. Abstract.
19. Neyroud N, Tesson F, Denjoy I, Leibovici M, Donger C, Barhanin J, Faure S, Gary F, Coumel P, Petit C, Schwanz K, Guicheney P. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielseri cardioauditory syndrome. Nat Genet. 1997;15:186-189.
20. Splawski I, Timothy KW, Vincent GM, Alkinson DL, Keating MT. Molecular basis of the long-QT syndrome associated with deafness. N EnglJ Med. 1997;336:1562-1567.
21. Priori SG, Schwanz PJ, Napolitano C, Bianchi L, Dennis A, De Fusco M, Brown AM, Casari G. A recessive variant of the Romano-Ward long QT syndrome? Circulation. 1998;97:2420-2425.
22. Vincent GM, Timothy KM, Leppert M, Keating M. The spectrum of symptoms and QT intervals in carriers of the gene for long QT syndrome. N EnglJ Med. I992;327:846-852.
23. Donger C, Denjoy I, Berthet M, Neyroud N, Cruaud C, Bennaceur M, Chivoret G, Schwanz K, Coumel P, Guicheney P. KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. Circulation. 1997;96:2778-2781.
24. Priori SG, Napolitano C, Schwanz PJ. Low penetrance in the long-QT syndrome: clinical impact. Circulation. 1999;99:529-533.
25. Neyroud N, Denjoy I, Donger C, Gary F, Villain E, Leenhardt A, Benali K, Schwanz K, Coumel P, Guicheney P. Heterozygous mutation in the pore of potassium channel gene KvLQTl causes an apparent normal phenotype in long QT syndrome. Ear J Hum Genet. I998;6:129-133.
26. Sanguinetti MC, Curran ME, Spector PS, Keating MT. Spectrum of HERG K-channel dysfunction in an inherited cardiac arrhythmia. Proc Nail Acad Sei USA. 1996;93:220S-2212.
27. Chouabe C, Neyroud N, Guiceney P, Lazdunski M, Romey G, Barhanin J. Properties of KvLQTl K channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias. EMBO J. 1997; 17:5472-5479.
28. Schwanz PJ, Moss AL, Priori SG, Wang Q, Lehmann MH, Timothy K, Denjoy IF, Haverkamp W, Guicheney P, Paganini V, Scheinman MM, Karnes PS. Gene-specific influence on the triggers for cardiac arrest in the long QT syndrome. Circulation. 1997;96(suppl I):I-2I2. Abstract.
29. Schwanz PJ, Priori SG, Locati EH, Napolitano C, Cantd F, Towbin JA, Keating MT, Hammoude H, Brown AM, Chen LS, Colatsky TJ. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to. Nachannel blockade and to increases in heart rate: implications for gene-specific therapy. Circulation. I995;92: 3381-3386.
30. Compton SJ. QT interval shortening by lidocaine in chromosome 7-linked long QT syndrome (LQTS). Pacing Clin Eleclrophysiol. I997;20:1060. Abstract.
31. Compton SJ, Lux RL, Ramsey MR, Strelich KR, Sanguinetti MC, Green LS, Keating MT, Mason JW. Genetically defined therapy of inherited long-QT syndrome: correction of abnormal repolarization by potassium. Circulation. 1996;94:1018 -1022.
32. Schwanz PJ, Moss AJ. QT interval prolongation: what does it mean? J Cardiovasc hied. 1982;7:1317-1330.,
33. Priori SO, Diehl L, Schwartz PJ. Torsade de pointes. In: Podrid PJ, Kowey PR, eds. Cardiac Arrhythmia, Mechanisms, Diagnosis and Management. Baltimore, Md: Williams & Wilkins; 1995:951-963.
34. Schulze-Bahr E, Haverkamp W, Hördt M, Borggrefe M, Wedekind H, Assmann G, Breithardt G, Funke H. A genetic basis forquinidine-induced (acquired) long QT syndrome. Enr Heart J. 1997;18:29. Abstract.
35. Napolitaho C, Priori SG, Schwanz PJ, Cantù F, Paganini V, De Fusco M, Pinnavaia A, Aquaro G, Casari G. Identification of a long QT syndrome molecular defect in drug-induced torsade de pointes. Circulation. 1997; 96(suppl I):I-211. Abstract.
36. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophie cardiomyopathy. N Engl J Med. I997;336:775-785.
37. Geisterfer LA, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE, Seidman JG. A molecular basis for familial hypertrophie cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell. 1990;62:999-1006.
38. Poetter K, Jiang H, Hassanzadeh S, Master SR, Chang A, Dalakas MC, Rayment I, Sellers JP, Fananapazir L, Epstein ND. Mutation in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet. 1996;13: 63-69.
39. Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, Seidman JG, Seidman CE. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophie cardiomyopathy: a disease of the sarcomere. Cell. 1994;77:701-712.
40. Bonne G, Carrier L, Bercovici J, Cruaud C, Richard P, Hainque B, Gautel M, Labeit S, James M, Beckmann J, Weissenbach J, Vosberg HP, Fiszman M, Komajda M, Schwartz K. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophie cardiomyopathy. Nat Genet. 1995;! 1:438-440.
41. Watkins H, Conner D, Thierfelder L, Jarcho JA, MacRae C, McKenna WJ, Maron BJ, Seidman JG, Seidman CE. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet. 1995;! 1:434-437.
42. Kimura A, Harada H, Park JE, Nishi H, Satoh M, Takahashi M, Hiroi S, Sasaoka T, Ohbuchi N, Nakamura T, Koyanagi T, Hwang TH, Choo JA, Chung KS, Hasegawa A, Nagai R, Okazaki O, Nakamura H, Matsuzaki M, Sakamoto T, Toshima H, Koga Y, Imaizumi T, Sasazuki T. Mutations in the cardiac troponin I gene associated with hypertrophie cardiomyopathy. Nat Genet. 1997;16:379-382.
43. MacRae CA, Ghaisas N, Kass S, Donnelly S, Basson CT, Watkins HC, Anan R, Thierfelder LH, McGarry K, Rowland E, McKenna WJ, Seidman JG, Seidman CE. Familial hypertrophie cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7p3. J Clin Invest. 1995;96:1216-1220.
44. Schwartz K, Carrier L, Guicheney P, Komajda M. Molecular basis of familial cardiomyopathies. Circulation. 1995;91:532-540.
45. Vikstrom KL, Leinwand LA. Contractile protein mutations and heart disease. Curr Opin Cell Biol. 1996;8:97-I05.
46. Carrier L, Bonne G, Bahrend E, Yu B, Richard P, Niel F, Hainque B, Cruaud C, Gary F, Labeit S, Bouhour JB, Dubourg O, Desnos M, Hagege AA, Trent RJ, Komajda M, Fiszman M, Schwartz K. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophie cardiomyopathy. Circ Res. I997;80:427-434.
47. Cuda G, Fananapazir L, Zhu WS, Sellers JR, Epstein ND. Skeletal muscle expression and abnormal function of -myosin in hypertrophie cardiomyopathy. J Clin Invest. 1993;91:2861-2865.
48. Lankford EB, Epstein ND, Fananapazir L, Sweeney HL. Abnormal contractile properties of muscle fibers expressing j3-myosin heavy chain gene mutations in patients with hypertrophie cardiomyopathy. J Clin Invest. 1995;95:1409-1414.
49. Sweeney HL, Straceski AJ, Leinwand LA, Tikunov BA, Faust L. Heterologous expression of a cardiomyopathic myosin that is defective an its actin interaction. J Biol Client. 1994:269:1603-1605.
50. Watkins H, Rosenzweig A, Hwang DS, Levi T, McKenna W, Seidman CE, Seidman JG. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophie cardiomyopathy. N Engl J Med. 1992;326:110S-1I14.
51. Dausse E, Komajda M, Fetler L, Dubourg O, Dufour C, Carrier L, Wisnewsky C, Bercovici J, Hengstenberg C, al-Mahdawi S, Isnard R, Hagege A, Bouhour J-B, Desnos M, Beckmann J, Weissenbach J, Schwanz K.Guicheney P, et al. Familial hypertrophie cardiomyopathy: microsatellite haplotyping and identification of a hot spot for mutations in the -myosin heavy chain gene. / Clin Invest. 1993;92:2807-2813.
52. Epstein ND, Cohn GM, Cyran F, Fananapazir L. Differences in clinical expression of hypertrophie cardiomyopathy associated with two distinct mutations in the -myosin heavy chain gene: a 908Leu-VaI mutation and a 403Arg-GIn mutation. Circulation. 1992;86:345-352.
53. Charron P, Dubourg O, Desnos M, Isnard R, Hagege A, Bonne G, Carrier L, Tesson F, Bouhour JB, Buzzi JC, Feingold J, Schwanz K, Komajda M. Genotype-phenotype correlations in familial hypertrophie cardiomyopathy: a comparison between mutations in the cardiac protein-C and the -myosin heavy chain genes. Ear Heart J. 1998;19:1377-1382.
54. Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O'Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG, Seidman CE. Mutations in the genes for cardiac troponin T and tropomyosin in hypertrophic cardiomyopathy. N Engl J Med. 1995;332:1058-1064.
55. Forissier JF, Carrier L, Farza H, Bonne G, Bercovici J, Richard P, Hainque B, Townsend PJ, Yacoub MH, Faure S, Dubourg O, Millaire A, Hagege AA, Desnos M, Komajda M, Schwanz K. Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophie cardiomyopathy. Circulation. 1996;94:3069-3073.
56. Moolman JC, Corfield VA, Posen B, Ngumbela K, Seidman C, Brink PA, Walkins H. Sudden death due to troponin T mutations. J Am Coll Cardiol. 1997;29:549-555.
57. Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M. Arrhythmogenic right ventricular cardiomyopathy: dysplasia, dystrophy, or myocarditis? Circulation. 1996;94:983-991.
58. Coonar AS, Protonotarios N, Tsatsopoulou A, Needham EWA, Houlston RS, Cliff S, Otter MI, Murday VA, Mattu RK, McKenna WJ. Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly hair (Naxos disease) maps to chromosome 17q21. Circulation. 1998;97:2049-2058.
59. Rampazzo A, Nava A, Danieli GA, Buja G, Daliento L, Fasoli G, Scognamiglio R, Corrado D, Thiene G. The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome I4q23-q24. Hum Mol Genet. 1994;3:959-962.
60. Severini GM, Krajinovic M, Pinamonti B, Sinagra G, Fioretti P, Brunazzi MC, Falaschi A, Camerini F, Giacca M, Mestroni L. A new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14. Genomics. 1996;31:193-200.
61. Rampazzo A, Nava A, Erne P, Eberhard M, Vian E, Slomp P, Tiso N, Thiene G, Danieli GA. A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome Iq42-q43. Hum Mol Genet. 1995;4:215I-2154.
62. Rampazzo A, Nava A, Miorin M, Fonderigo P, Pope B, Tiso N, Livolsi B, Zimbello R, Thiene G, Danieli GA. ARVD4, a new locus for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 2 long arm. Genomics. 1997;45:259-263.
63. Michels VV, Moll PP, Miller FA, Tajik AJ, Chu JS, Driscoll DJ, Bumett JC, Rodeheffer RJ, Chesebro JH, Tazelaar HD. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med. 1992:326:77-82.
64. Stamato NJ, O'Connell JB, Murdock DK, Moran JF, Loeb HS, Scanlon PJ. The response of patients with complex ventricular arrhythmias secondary to dilated cardiomyopathy to programmed electrical stimulation. Am Heart J. 1986;! 12:505-508.
65. Stevenson WG, Stevenson LW, Weiss J, Tillisch JH. Inducible ventricular arrhythmias and sudden death during vasodilator therapy of severe heart failure. Am Heart J. 1988:116:1447-1454.
66. Schultz KR, Gajarski RJ, Pignatelli R, Goytia V, Roberts R, Bachinski L, Towbin JA. Genetic heterogeneity in familial dilated cardiomyopathy. Biochem Mol Med. 1995:56:87-93.
67. Towbin JA, Hejtmancik JF, Brink P, Gelb B, Zhu XM, Chamberlain JS, McCabe ER, Swift M. X-Iinked dilated cardiomyopathy: molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation. 1993;87:1854-1865.
68. Ortiz-Lopcz R, Li H, Su J, Goytia V, Tcmbin JA. Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. Circulation. 1997;95:2434-2440.
69. Bione S, D'Adamo P, Maestrini E, Gedeon AK, Bolhuis PA, Toniolo D. A novel X-linked gene, G4.5, is responsible for Earth syndrome. A'or Genet. 1996;12:385-389.
70. Muntoni F, Cau M, Ganau A, Congiu R, Arvedi G, Mateddu A, Marrosu MG, Cianchetti C, Realdi G, Cao A, Melis MA. Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med. I993;329:921-925.
71. Muntoni F, Wilson L, Marrosu G, Marrosu MG, Cianchetti C, Mestroni L, Ganau A, Dubowitz V, Sewry C. A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart. J Clin Invest. 1995;96:693-699.
72. Milasin J, Muntoni F, Severini GM, Bartoloni L, Vatta M, Krajinovic M, Mateddu A, Angelini C, Camerini F, Falaschi A, Mestroni L, Giacca M. A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. Hum Mol Genet. 1996; 5:73-79.
73. Durand JB, Bachinski LL, Bieling LC, Czernuszewicz GZ, Abchee AB, Yu QT, Tapscott T, Hill R, Ifegwu J, Marian AJ, Brugada R, Daiger S, Gregoritch JM, Anderson JL, Quinones M, Towbin JA, Roberts R. Localization of a gene responsible for familial dilated cardiomyopathy to chromosome Iq32. Circulation. 1995;92:3387-3389.
74. Siu BL. A novel locus for familial dilated cardiomyopathy on chromosome 2p31. Proc Second World Congress of Pédiatrie Cardiology and Cardiac Surgery. 1997.
75. Krajinovic M, Pinamonti B, Sinagra G, Vatta M, Severini GM, Milasin J, Falaschi A, Camerini F, Giacca M, Mestroni L, Heart Muscle Disease Study Group. Linkage of familial dilated cardiomyopathy to chromosome 9. Am J Hum Genet. 1995:57:846-852.
76. Bowles KR, Gajarski R, Porter P, Goytia V, Bachinski L, Roberts R, Pignatelli R, Towbin JA. Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23. J Clin Invest. 1996; 98:1355-1360.
77. Kass S, MacRae C, Graber HL, Sparks EA, McNamara D, Boudoulas H, Basson CT, Baker PR, Cody RJ, Fishman MC, Cox N, Kong A, Wooley CF, Seidman JG, Seidman CE. A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome Ipl-Iql. Nat Genet. 1994;7:546-551.
78. Olson TM, Keating MT. Mapping a cardiomyopathy locus to chromosome 3p22-p25. J Clin Invest. I996;97:528-532.
79. Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT. Actin mutations in dilated cardiomyopathy: a heritable form of heart failure. Science. 1998:280:750-753.
80. Consensus statement of the Joint Steering Committees of UCARE and of IVF-US (Bardy GH, Bigger JT Jr, Borggrefe M, Camm AJ, Cobb LA, Ewy GA, Hauer RNW, Kuck KH, Lane RD, Lazzara R, Marcus FI, Muller JE, Myerburg RJ, Priori SG, Schwanz PJ, Touboul P, Verrier RL, Wellens HJJ, Zipcs DP). Survivors of out-of-hospital cardiac arrest with apparently normal heart: need for definition and standardized clinical evaluation. Circulation. 1997;95:265-272.
81. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J Am Coll Cardiol. 1992;20: 1391-1396.
82. Chen Q, Kirsch CE, Zhang D, Brugada R, Brugada J, Brugada P, Potenza D, Moya A, Borggrefe M, Breithardt G, Ortiz-Lopez R, Wang Z, Antzelevitch C, O'Brien RE, Schulze-Bahr E, Keating MT, Towbin JA, Wang Q. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature. 1998;392:293-294.
83. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. GVru/mo 1995;92:I954-196S.
84. van der Velden HMW, van Zijverden M, van Kempen MJA, Wijffels MCEF, Groenewegen WA, Allessie MA, Jongsma HJ. Abnormal expression of the gap junction protein connexin 40 during chronic atrial fibrillation in the goat. Circulation. 1996;94(suppl I):I-593. Abstract.
85. Yue L, Feng J, Gaspo R, Li GR, Nattel S. Ionic remodeling underlying tachycardia-induced atrial fibrillation in dogs. Circulation. 1996;94(suppl I):I-592. Abstract.
86. Ticleman RG, De LC, Van GI, de KP, Grandjean J, Bel KJ, Wijffels MC, Allessie MA, Crijns HJ. Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation. 1997;95:1945-1953.
87. Satoh T, Zipes DP. Unequal atrial stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation. J Cardiovasc Elcctrophysiol. 1996;7:833-842.
88. Yue L, Feng J, Gaspo R, Li GR, Wang Z, Nattel S. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res. 1997;81:512-525.
89. Brugada R, Tapscott T, Czernuszewicz GZ, Marian AJ, Iglesias A, Mont L, Brugada J, Girona J, Domingo A, Bachinski LL, Roberts R. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med. 1997;336:905-911.
90. Brink PA, Ferreira A, Moolman JC, Weymar HW, van der Merwe PL, Corfield VA. Gene for progressive familial heart block type I maps to chromosome 19ql3. Circulation. 1995;91:1633-1640.
91. Brink AJ, Torrington M. Progressive familial heart block: two types. S Afr MedJ. 1977;52:53-59.
92. De Meeus A, Stephan E, Debrus S, Jean MK, Loiselet J, Weissenbach J, Démaille J, Bouvagnet P. An isolated cardiac conduction disease maps to chromosome 19q. Circ Res. 1995;77:735-740.
93. Priori SG. Is long QT syndrome entering the era of molecular diagnosis? Heart. I997;77:5-6.
94. + channel blockade, β-adrenergic stimulation, and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long-QT syndrome. Circ Res. 1996;78:1009-1015.